InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Hall Ashley. Director active across 2 companies, notably Reneo Pharmaceuticals, Inc.. In total, 7 reports have been published. History available since 12 November 2021. The latest transaction was filed on 19 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Hall Ashley is a declarant linked to Structure Therapeutics Inc. and Reneo Pharmaceuticals, Inc., where the listed role is Chief Development Officer. The record shows 7 filings in total, and among the recent filings tracked, the activity runs from 2021-11-15 to 2026-03-23, with a modal transaction nature of Attribution and buy and sell amounts at EUR 0.